title: Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
authors.affiliation: Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Hernández
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: A
authors.initials: A
authors.lastname: Andrés
authors.forename: B
authors.initials: B
authors.lastname: Ortuño
authors.forename: M
authors.initials: M
authors.lastname: Praga
authors.forename: J M
authors.initials: JM
authors.lastname: Alcazar
authors.forename: G
authors.initials: G
authors.lastname: Fernández
authors.forename: J L
authors.initials: JL
authors.lastname: Rodicio
mesh_terms: D002216:Captopril / Q000009:adverse effects / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D004921:Erythropoietin / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy*; D011188:Potassium / Q000097:blood; D013997:Time Factors
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin; D002216:Captopril; D003404:Creatinine; D009543:Nifedipine; D011188:Potassium